Kavitha J Ramachandran - JoVE Visualize

Showing results (1-10 of 2) with videos related to

Pageof 1

Sort By:

Journal of Clinical Neuromuscular Disease|November 14, 2023

Plasma Exchange in Patients With Myositis due to Immune Checkpoint Inhibitor TherapyNakul Katyal, Tamiko R Katsumoto, Kavitha J Ramachandran, et al.

JCO Precision Oncology|June 21, 2021

Randomized Phase II Study of 3 Months or 2 Years of Adjuvant Afatinib in Patients With Surgically Resected Stage I-III EGFR-Mutant Non-Small-Cell Lung CancerJoel W Neal, Daniel B Costa, Alona Muzikansky, et al.

Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:

Pageof 1

Journal of Clinical Neuromuscular Disease|November 14, 2023

Plasma Exchange in Patients With Myositis due to Immune Checkpoint Inhibitor TherapyNakul Katyal, Tamiko R Katsumoto, Kavitha J Ramachandran, et al.

JCO Precision Oncology|June 21, 2021

Randomized Phase II Study of 3 Months or 2 Years of Adjuvant Afatinib in Patients With Surgically Resected Stage I-III EGFR-Mutant Non-Small-Cell Lung CancerJoel W Neal, Daniel B Costa, Alona Muzikansky, et al.

Pageof 1